One out of every 100 confirmed COVID-19 patients were found to have been prescribed oral COVID-19 treatments (Paxlovid·Lagevrio).

According to the data NA’s Health and Welfare Committee member Hyun-Young Shin of the Democratic Party of Korea received from the Korea Disease Control Prevention and Control Agency on the 5th, a total of 124,571 patients were administered oral treatments from January 14th to March 26th of this year.

A total of 39,747 patients were reported to have been administered the drug at medical institutions. 87.8% of the patients were over the age of 60. Specifically, 35.8% were in their 60s, 24.1% were in their 70s, and 27.9% were 80 years old or older.